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Background: Electrical impedance tomography (EIT) generates images of the lungs
based on impedance change and was able to detect changes in airflow after hista-
mine challenge in horses.
Objectives: To confirm that EIT can detect histamine-provoked changes in airflow
and subsequent drug-induced bronchodilatation. Novel EIT flow variables were
developed and examined for changes in airflow.
Methods: Bronchoconstriction was induced using stepwise histamine bro-
nchoprovocation in 17 healthy sedated horses. The EIT variables were recorded at
baseline, after saline nebulization (control), at the histamine concentration causing
bronchoconstriction (Cmax) and 2 and 10 minutes after albuterol (salbutamol) adminis-
tration. Peak global inspiratory (PIFEIT) and peak expiratory EIT (PEFEIT) flow, slope of
the global expiratory flow-volume curve (FVslope), steepest FVslope over all pixels in
the lung field, total impedance change (surrogate for tidal volume; VTEIT) and inter-
cept on the expiratory FV curve normalized to VTEIT (FVintercept/VTEIT) were indexed
to baseline and analyzed for a difference from the control, at Cmax, 2 and 10 minutes
after albuterol. Multiple linear regression explored the explanation of the variance of
Δflow, a validated variable to evaluate bronchoconstriction using all EIT variables.
Results: At Cmax, PIFEIT, PEFEIT, and FVslope significantly increased whereas
FVintercept/VT decreased. All variables returned to baseline 10 minutes after albuterol.
The VTEIT did not change. Multivariable investigation suggested 51% of Δflow vari-
ance was explained by a combination of PIFEIT and PEFEIT.
Conclusions and Clinical Importance: Changes in airflow during histamine challenge
and subsequent albuterol administration could be detected by various EIT flow vol-
ume variables.
Abbreviations: A10min, 10 minutes post albuterol administration; A2min, 2 minutes post albuterol administration; AU, arbitrary units; Cmax, histamine concentration causing maximal
bronchoconstriction; EIT, electrical impedance tomography; FP, flowmetric plethysmography; FVintercept/VTEIT, the intercept between the steep and the horizontal part of the expiratory flow
volume EIT loop, and given as the ratio between intercept to VTEIT; FVslope, global steepness of the slope of the initial expired volume of the expiratory EIT FV loop; FVslopemax, the value of the
steepest slope of all the FV loops generated within the ROI; PEFEIT, EIT peak global expiratory flow; PEFSpiro, pneumotachograph peak expiratory flow; PIFEIT, EIT peak global inspiratory flow;
PIFSpiro, pneumotachograph peak inspiratory flow; RIP, respiratory inductance plethysmography; ROI, region of interest; VTEIT, EIT tidal volume; VTSpiro, pneumotachograph tidal volume; Δflow,
validated FP variable; Δflow, validated FP variable.
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1 | INTRODUCTION
Mild to moderate asthma in horses commonly is diagnosed based on
clinical signs, increased tracheal mucus viewed on endoscopy, and
bronchoalveolar lavage cytology.1,2 It is unclear which diagnostic tool
is most appropriate because a clinically applicable objective lung func-
tion test is not readily available. The lack of alignment in diagnostic
approach between practitioners and international consensus presents
a barrier to advancing evidence-based practice2,3 and there is a need
for a sensitive diagnostic tool, ideally accessible and noninvasive, that
can provide an objective measurement of lung function in the field.
Such devices would best detect subtle to marked alteration in lung
mechanics, which occurs across the range of manifestations seen in
the stages of asthma in horses.1
Electrical impedance tomography (EIT) is a noninvasive, radiation-
free functional imaging modality, which allows assessment of ven-
tilation of conscious and anesthetized horses.4-6 The fundamental
principle of EIT is Ohm's law which describes the resistance of tissue
to electrical current from measurements of voltage. Alternating
currents are used instead of direct current making impedance the
main outcome measure for EIT as the analogue to resistance. Lung
tissue impedance changes during breathing as a function of air con-
tent. Electrodes equidistantly mounted on a belt are placed around the
thorax. Weak alternating currents are applied and voltages measured
between pairs of electrodes. From these measurements, changes in
impedance within the thorax can be calculated and cross-sectional
images of the distribution of impedance changes within the thorax are
displayed 50 times per second. Based on the reported linear relationship
between EIT impedance change and changes in lung air volume, it can
be assumed that impedance change correlates with gas volume, and
total impedance change over a single breath can be used as a surrogate
for tidal volume.7-9 Therefore, peak inspiratory (PIFEIT) and peak expira-
tory (PEFEIT) global flow can be evaluated by calculating the first deriva-
tive of the global EIT volume signal.10 Electrical impedance tomography
derived flow signals have been shown to detect changes in airflow during
histamine bronchoprovocation in horses.11 In that pilot study, flowmetric
plethysmography (FP) described by the variable delta flow (Δflow) was
compared against regional and global peak inspiratory and expiratory
flow variables calculated from the EIT measurements. Although EIT flow
variables and Δflow represent different measurement principles of flow,
EIT flow variables were shown to follow the same pattern of change as
Δflow over the duration of the histamine challenge. The authors con-
cluded that EIT has potential as a noninvasive, objective diagnostic tool
to monitor airflow changes occurring in horses with asthma.
Our aim was to confirm the observation noted for EIT flow variables
in the pilot study by examining histamine-provoked changes in airflow in
a larger population of horses and to determine if novel EIT variables
could provide additional information on changes in breathing pattern
during bronchoconstriction, as well as evaluate subsequent airflow
changes after drug-induced bronchodilatation. A secondary aim was to
compare EIT flow variables with the corresponding flow variables mea-
sured using a pneumotachograph and the validated FP variable Δflow.
It was hypothesized that all EIT-derived variables would change
during histamine challenge and return to preprovocation levels after
drug-induced bronchodilatation. Secondarily, it was hypothesized that
EIT flow variables would follow the same pattern as standard flow
variables and Δflow, and finally that the variance in Δflow could be
best explained by the EIT flow variables.
2 | MATERIALS AND METHODS
2.1 | Animals
Twenty horses (12 Standardbreds and 8 Thoroughbreds) from the
institutional teaching herd were included. The horses included 3 mares
and 17 geldings, with a mean (SD) age of 11.7 (7.9) years and body
weight of 511 (64) kg. The median (range) body condition score was
6 of 9 (range, 5-7/9).12 Horses were considered clinically healthy
based on clinical examination and long-term history. Before the study,
the horses were housed in an irrigated paddock and received supple-
mental feed of meadow hay.
2.2 | Preparation
Each horse was walked into stocks and had an 18G catheter (Surflo,
Terumo, Philippines) aseptically placed in the right jugular vein. The
horse then was sedated with a loading dose of 5 μg/kg of detomidine
(Detomo Vet, Ceva, Glenorie, NSW, Australia) IV before immediately
receiving a detomidine constant rate infusion (12.5 μg/kg/hour)
administered through a fluid pump. The hair over the thorax directly
caudal to the scapula (5th-6th intercostal space) was moistened with
water and electrically nonconductive ultrasound gel was applied cir-
cumferentially in this region. Thereafter, a stretchable neoprene EIT
belt with 32 equidistantly-mounted stainless steel electrodes was
placed under slight tension around the thorax on top of the gel.
Contact with the skin was maintained by application of a cohesive
stretchable bandage placed over the EIT belt. The belt was connected
to the EIT device (BBvet, SenTec AG, Landquart, Switzerland).
Sufficient contact of the electrodes with the skin was verified by
the EIT software and visual inspection of adequate electrode-skin
resistance values during the study period. The EIT measurements
were performed with 47 impedance tomograms per second.
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A modified Graz consensus reconstruction algorithm for EIT (GREIT)13
adapted for horse anatomy was used to generate EIT images for each
horse, representing breathing-related regional changes of impedance.
Additional details on the use of EIT technology and image reconstruc-
tion are reported in the literature.13-16
Each horse was concurrently fitted with FP hardware to measure
the effect of histamine bronchoprovocation on Δflow (Open Plethys-
mography, Ambulatory Monitoring, Ardsley, New York). A facemask,
pneumotachograph (No. 5 Fleisch), and abdominal and thoracic respi-
ratory inductance plethysmography bands (RIP), which make up the
FP unit, were fitted to the horse and calibrated according to the man-
ufacturer's instructions.17 Head carriage was maintained on a stand in
a consistent horizontal position to avoid nasal edema.18
2.3 | Histamine bronchoprovocation
Data collection commenced 10 minutes after the initiation of the
detomidine constant rate infusion and fitting of all devices. Data was col-
lected in each animal before treatment (baseline), after nebulization (Pari
LC Plus reusable nebulizer, Pari Respiratory Equipment, Midlothian, Vir-
ginia) of saline alone (control), after nebulization of histamine diphos-
phate in saline solution in increasing concentrations until predefined
endpoints were reached. Each solution was nebulized for 2 minutes. At
each examination point, lung function data was recorded for 3 minutes
using the EIT, spirometry and the FP system simultaneously.
Saline (0.9%) was nebulized as a control for reaction to diluent
followed by series of increasing doses of histamine diphosphate in
saline solution, starting with 4 mg/mL (4, 8, 16, 32 mg/mL) until at
least 1 of the following 2 criteria was reached: (a) observation of sub-
jective changes in breathing pattern corresponding to changes in air-
way diameter (increase in abdominal expiratory effort and respiratory
rate) and an objective increase of Δflow of 50% over the control
response, or (b) a maximum concentration of 32 mg/mL of histamine
diphosphate was reached according to the manufacturer's instruc-
tions.17 This time point was referred to as Cmax.
After reaching 1 of the 2 described end points and data collection
for Cmax, albuterol sulfate (Ventolin, GlaxoSmithKline, Victoria,
Australia) was administered into the face mask using a metered dose
inhaler (100 μg/actuation to ideally dose at 2 μg/kg). One puff was
administered via the nebulizer port of the face mask at the beginning
of each inspiration until the predefined dose was reached. Data col-
lection for 3 minutes started 2 minutes (A2min) and 10 minutes (A10min)
after the last puff was administered. Once data collection for A2min
and A10min was complete, all instruments and devices were removed,
the detomidine CRI stopped, and the horse was observed for an addi-
tional 10 minutes in the stocks before being returned to the paddock.
2.4 | Electrical impedance tomography variables
A sequence of at least 8 and a maximum of 22 breaths free of any move-
ment artifacts was preselected for each time point depending on the
respiratory rate and cooperation of the horse during the 3-minute mea-
surement period using a dedicated software (Ibex, SenTec AG, Land-
quart, Switzerland).19 Breaths with obvious movement artifacts were
removed manually. The EIT signal of each preselected sequence was
exported and analyzed using custom software,20 which is available as
part of EIDORS.21 The following variables were derived from the EIT
signal:
2.4.1 | Gas flow variables and EIT-derived tidal
volume
The global impedance changes, representing the EIT volume signal in
arbitrary units (AU), was calculated as the sum of all pixels within the
entire EIT image. The tidal volume-related EIT factor VTEIT was calculated
by subtracting the impedance distribution at start of inspiration from the
impedance distribution at end of inspiration (Figure 1A).7-9 From the
EIT volume signal, the global EIT gas flow was calculated as the first
derivative of the global volume over each breath (Figure 1A).10 From
the flow signal, global peak inspiratory (PIFEIT) and global peak expira-
tory (PEFEIT) flow were calculated for the whole lung for each breath.
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2.4.2 | Flow-volume loop variables
From the obtained flow and volume signal, a global EIT flow-volume
(FV) loop (Figure 1B) and a FV loop for each pixel within the lung region
of interest (ROI) were constructed. The FV loops were visually inspected
to determine if a biphasic pattern could be identified. The slope of the
expiratory portion of the FV loop was determined by the software algo-
rithm. For each breath, the first part after peak expiration was analyzed
and the slope of the best-fit line taken (black aspect of FV loop;
Figure 1B). The FV slope was the averaged over all measured breaths.
The steepness of slopes of each pixel FV loop within the ROI was calcu-
lated and the value of the steepest slope in all FV loops generated within
the lung area was identified (FVslopemax; Figure 1C).
A distinct change in flow during expiration was observed, where
the flow became constant over the final proportion of expiration. A
novel variable was defined, determined by manual measurement of
the intercept between the steep and the horizontal part of the expira-
tory FV loop. The mean intercept of all FV loops is given as the ratio
between intercept to VTEIT (FVintercept/VTEIT; Figures 2 and 1D).
2.5 | Spirometry and flowmetric plethysmography
variables
Peak inspiratory (PIFSpiro), peak expiratory (PEFSpiro) flows and tidal volume
(VTSpiro) were measured using a calibrated Fleisch pneumotachograph.
The commercial FP system (Open Plethysmography, Ambulatory
Monitoring, Ardsley, New York) utilized software to derive a
flow factor, Δflow, which was calculated based on spirometry
and respiratory inductance band measurements by FP software.
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This flow factor measures the maximum difference between the flow
derived from the pneumotachograph and the calibrated flow from
the respiratory inductance bands.17 Delta flow has been validated as
a variable that can detect narrowing in airway diameter after hista-
mine bronchoprovocation.18,22 The same software was used to
record the spirometry data measured by the pneumotachograph.
2.6 | Data analysis
For each variable, an average was calculated across all breaths at each
time point for each horse. This value was the response of interest for
statistical analysis. All variables at each examination point were inde-
xed for each horse as a fraction of the baseline (yi = Ci/BL  1); where
F IGURE 1 Electrical impedance tomography (EIT) measurements from 1 horse at baseline, after saline nebulization as control, at maximum
bronchoconstriction (Cmax) and 2 (A2min) and 10 (A10min) after albuterol administration. A, The impedance curve measured by EIT representing the
volume signal in blue and the corresponding flow signal in purple calculated as the first derivative from the volume signal plotted against time.
Volume and flow are measured in EIT arbitrary units (AU). B, The global flow volume (FV) loop obtained from the EIT flow and volume signal and
the FV slope in early expiration marked in black. C, Pictorial representation of the steepness of slopes of FV loop for each pixel within the lung
regions and the value of the steepest slope (lightest color) in all FV loops generated within the lung area (FVslopemax). D, The EIT FV loop
duplicated on a grid to determine a novel variable of the expiratory component of the FV loop namely the FV intercept as the ratio between
intercept to EIT derived tidal volume (FVintercept/VTEIT) (Figure 2)
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Ci is the value measured at administration of saline (diluent control),
histamine concentration when bronchoprovocation was deemed to
have occurred (Cmax), or administration of albuterol at 2 minutes or
10 minutes post-administration. Each index was verified to follow a
normal distribution at each examination point by inspection of Q-Q
plots and failure to reject the null hypothesis of normality using the
Shapiro-Wilk statistic at P < .05.
Indexed variables for examination points beyond baseline were
evaluated for a difference at each intervention (time) using a mixed
linear model accounting for repeated measurements. A compound
symmetry covariance structure was used, which assumes that the cor-
relation between 2 measurements is the same, regardless of how far
apart they are. Least squares means at each examination point were
generated and compared to the null hypothesis of the diluent control
(saline) value for all indexed variables. All analyses were considered
significant at a Dunnett-adjusted P ≤ .05.
To explore the explanation of the variance of Δflow, multiple lin-
ear regression was used with all EIT variables entered into the model
and the best variable subset chosen based on adjusted R2 and Mal-
low's p (Cp). Commercial software (SAS v 9.4, SAS Institute, Cary,
North Carolina) was used for the analysis.
3 | RESULTS
Twenty horses were enrolled in the study (Figure 3), 19 horses
allowed instrumentation of both the EIT and FP hardware and
accepted subsequent histamine bronchoprovocation and recovered as
expected. All horses received the diluent control nebulization (saline),
and the endpoints of histamine provocation (Cmax) were reached at
various concentrations of histamine (Figure 3). On examination of the
data posttesting, FP data could not be used in 1 horse because
the RIP bands ceased to register a signal midway through the proce-
dure. The 2 RIP bands caused interference with the EIT data collection
in some horses that sweated excessively (an example of mild interfer-
ence is seen in Figure 1A,B in breath 3 of the saline measurement). In
1 horse, interference made EIT data analysis unusable. Both EIT and
FP data sets were available in 17 horses.
Horses showed significantly higher indexed EIT flow variables
(PIFEIT: P < .001, PEFEIT: P < .001), indexed spirometry variables
(PIFSpiro: P = .01, PEFSpiro: P = .02) and FP flow index, Δflow (P = .002)
as well as respiratory rate (P < .001) at Cmax compared to the diluent
control nebulization (saline; Table 1). All values were lower at A2min and
were not significantly different from the control values at A10min
(Table 1). The global peak flow EIT indices PIFEIT and PEFEIT followed
the same pattern of change as PIFSpiro and PEFSpiro as well as Δflow
measured by flowmetric plethysmography (Figure 4).
Computing of FV loops was possible in 16/17 data sets. A
biphasic flow pattern on the inspiratory part of the FV loop was
observed after the administration of the control (n = 13), Cmax (n = 2),
A2min (n = 3), and A10min (n = 4). A biphasic flow pattern on the expira-
tory part of the FV loop was observed after the control nebulization
(n = 16), Cmax (n = 15), A2min (n = 16), and A10min (n = 15).
The FVslope at Cmax was significantly higher (P = .03; Table 1) than
at control nebulization but was not significantly different from control
at A2min and A10min (Figure 5). Although FVslopemax followed the same
F IGURE 2 Graphical illustration of flow volume loops generated from 6 breaths during the measurements at baseline (A) and Cmax (B) in the
same horse as in Figure 1 and determination of the intercept in the FV loop (FVintercept/VTEIT). The volume change during inspiration and
expiration are indicated by arrows. The expiratory portion of the curve is depicted by the portion of the loop with positive flow. The volume
increase during inspiration is plotted toward the left on the x-axis. The computing of the FV intercept slopes and lines are depicted in green and
brown. The FV intercept is indicated by a red line and is the percentage of the expiratory portion of the flow volume loop where flow is constant
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pattern, the change between the control nebulization and Cmax was
not significant. The FVintercept/VT EIT was significantly lower (P < .001)
at Cmax, but not significantly different from the control nebulization at
A2min and A10min (Figure 5). The variables VTEIT and VTSpiro were not
significantly different from the control nebulization values at any mea-
surement point (Table 1).
Further analysis of all 5 EIT variables showed the variance in
Δflow was best described by the variance in both flow variables,
PIFEIT and PEFEIT, with an adjusted R
2 of 0.51. When FVslope was
included, the adjusted R2 increased to 0.53.
4 | DISCUSSION
The aim of our study was to investigate whether histamine-provoked
changes in airflow and subsequent drug-induced bronchodilatation
can be detected using noninvasive EIT measurements, motivated by
promising findings in a pilot study.11 Results showed global EIT peak
flows can detect airflow changes during histamine challenge, and that
EIT could detect a reversal of airflow changes induced by the adminis-
tration of albuterol after histamine challenge. Additionally, novel vari-
ables (FVslope and FVintercept/VTEIT) derived from the flow-volume
curve of the EIT signal were identified as also detecting airflow
changes. Similar to the peak flows measured by spirometry and the
primary FP variable, Δflow, these EIT-derived flow indices significantly
changed after histamine administration and returned to control values
with subsequent albuterol administration.
Inhaled histamine has been shown to induce bronchoconstriction
through activation of H1 receptors,23 and peak flows increase within
the airways. 11,24 This is true in both histamine-induced
bronchoconstriction and the natural disease state of severe asthma in
horses.25-28 Both devices, the EIT and the pneumotachograph, regis-
tered significantly higher measurements of inspiratory and expiratory
peak flows during Cmax (Figure 4). This result shows that global EIT
flow variables, based on the assumption that the measured impedance
change corresponds with inhaled and exhaled volume, follow the
F IGURE 3 Flow diagram documenting the experimental timeline
and exclusions. Cmax, histamine concentration causing maximal
bronchoconstriction; EIT, electrical impedance tomography; FP,
flowmetric plethysmography
TABLE 1 Mean (±SD) values for electrical impedance tomography (EIT), spirometry and flowmetric plethysmography (FP) for 17 horses
challenged with the diluent control (saline), increasing histamine doses (4, 8, and 16 mg/mL), and subsequent albuterol administration (A2min and
A10min)
Control (saline) Cmax A2min A10min
PIFEIT (AU) 1.86 (0.55) 3.20 (1.99)
a 2.50 (0.89)a 2.22 (0.65)
PEFEIT (AU) 2.56 (0.87) 4.09 (1.72)
a 2.87 (1.16) 2.54 (1.04)
FVslope 0.97 (0.47) 1.47 (0.55)
a 1.22(0.47) 1.15(0.60)
FVslopemax 2.53 (0.87) 3.23 (1.12) 2.74 (0.90) 2.59 (0.92)
FVintercept/VT EIT 54.22 (12.25) 37.58 (14.32)
a 47.72 (12.95) 52.57 (13.78)
VTEIT (AU) 5.14 (0.91) 5.03 (1.21) 4.87(1.77) 4.76 (1.01)
Respiratory rate (bpm) 8.83 (2.68) 15.60 (7.10)a 12.25 (4.34) 10.48 (4.34)
PIFSpiro (L/s) 3.57 (1.01) 4.97 (2.10)
a 3.82 (1.57) 3.84 (1.42)
PEFSpiro (L/s) 4.04 (1.79) 5.56 (3.11)
a 3.90 (2.73) 3.62 (2.72)
Δflow 0.76 (0.60) 1.97 (1.26)a 1.69 (1.17)a 1.68 (1.01)
VTSpiro (L) 6.23 (1.62) 6.18 (2.17) 5.60 (2.23) 6.56 (1.93)
Notes: FVintercept/VTEIT, the intercept between the steep and the horizontal part of the expiratory FV EIT; FVslope, global steepness of the slope of the initial
expired volume of the expiratory EIT FV loop; FVslopemax, the value of the steepest slope of all the FV loops generated within the ROI; PEFEIT, EIT peak
global expiratory flow; PEFSpiro, pneumotachograph peak expiratory flow; PIFEIT, EIT peak global inspiratory flow; PIFSpiro, pneumotachograph peak
inspiratory flow; VTEIT, EIT tidal volume; VTSpiro, pneumotachograph tidal volume.
aSignificant difference from the saline control.
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same pattern as airflow changes measured by a calibrated pneumo-
tachograph during histamine challenge.
Our study showed that EIT also could detect airflow changes
associated with bronchodilatation induced by albuterol. Albuterol has
been shown to be effective in decreasing histamine induced contrac-
tion of equine bronchial muscle in vitro,29,30 as well as being effective
in inducing bronchodilatation in the natural disease state of severe
asthma in horses.31-34 This finding supports the use of EIT and its vari-
ables as a possible monitoring tool to assess treatment success in
horses with asthma. Future studies on naturally occurring asthma
in horses are necessary to explore this application.
To our knowledge, this study describes for the first time the
computing of a FV loop from the EIT signal in veterinary medicine.
The shape of the FV loop our study suggests a biphasic inspiratory
and expiratory breathing pattern in most horses before the adminis-
tration of histamine. This biphasic pattern also has been described
in horses at rest using spirometry,25,26,35 and in combination with
electromyography.36 During histamine challenge at Cmax, the biphasic
pattern of the EIT-derived FV loop was lost in all but 2 horses during
inspiration, whereas a distinct biphasic pattern still was observed
during expiration in all but 1 horse. Loss of the biphasic pattern of the
FV loop in both inspiration and expiration has been described in
horses with severe asthma.25,26
The shape of FV loops with a high peak expiratory flow early in
expiration followed by a low flow rate has been described in horses
during severe airway obstruction.26 To quantify the expiratory flow
pattern observed in the EIT-derived FV loop, a global variable that
described the shape of the global FV loop (FVslope) and 1 regional vari-
able that identified the pixel with the steepest slope within the ROI
and quantifies the steepness (FVslope max) were designed (Figure 1C).
At Cmax, the FVslope was significantly higher than the control and sub-
sequently returned to the control values after albuterol administra-
tion, suggesting that this variable can be used to describe changes in
airflow in horses. The FVslopemax followed the same pattern as
FVslope, but the change was not significant. One reason for lack of sig-
nificance was that both FVslope and FVslopemax displayed marked vari-
ability among horses. In some horses, the RIP bands of the FP unit,
which applies a current traveling through the thoracic and abdominal
bands, resulted in interference with the measured EIT signal, which
influenced the plotting of the FV loop and made the computing of
these 2 variables challenging for the software. The clinical usefulness
of both EIT slope variables should be further explored in the absence
of FP hardware.
The RIP bands used in FP have been used to assess changes in
the breathing pattern of horses during airflow changes.25 Our inten-
tion was to create an EIT variable that identified these changes in
F IGURE 4 Mean (SD) global peak flow indices measured by electrical impedance tomography (EIT; • PIFEIT, ∎ PEFEIT) and spirometry (▲
PIFSpiro, ▼ PEFSpiro; A) and the Δflow index (•) measured by flowmetric plethysmography (B) at baseline, after control nebulization (saline), at
time of maximum histamine concentration when bronchoprovocation was deemed to have occurred (Cmax), 2 minutes post albuterol
administration (A2min) and 10 minutes post albuterol (A10min). All variables were indexed for each horse as a fraction of baseline (yi = Ci/BL  1;
where Ci is the value measured with each examination point, respectively. * indicates values significantly different from the control nebulization
F IGURE 5 Graph showing the mean (SD) change in flow volume
(FV) loop indices (• FVslope, ∎ FVslopemax, and▲ FVintercept/VTEIT)
measured by electrical impedance tomography (EIT) at baseline, after
administration of the control nebulization (saline), at time of maximum
histamine concentration when bronchoprovocation was deemed to
have occurred (Cmax), 2 minutes post albuterol administration (A2min)
and 10 minutes post albuterol administration (A10min). All variables
were indexed for each horse as a fraction of baseline (yi = Ci/BL  1;
where Ci is the value measured with each intervention respectively
and saline is the value at saline measurement for the given variable.
* indicates values significantly different from the control nebulization
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breathing pattern as well. Similar to previous findings,26 we also
observed an abrupt change in steepness of the expiratory curve slope
in the FV loop with the slope becoming almost horizontal (Figure 2).
The commencement of the horizontal part of the expiratory curve
was subjectively synchronous with the activation of the abdominal
muscles based on observation during the histamine challenge. This
could be the component of the breathing cycle that maintains flow
and decreases lung volume below the relaxed volume or functional
residual capacity at the completion of passive exhalation, and forms
the active component of the expiratory cycle as has been described in
healthy horses.36 This change in flow was observed later in expiration
during the histamine challenge when compared to baseline or after
saline (control) nebulization. In an attempt to quantify this flow transi-
tion, a novel variable representing this point of change was created by
calculating a ratio of between the intercept (between the steep and
the horizontal part of the expiratory FV loop) and the tidal volume
(FVintercept/VT EIT; Figures 2 and 1D). This variable was significantly
lower after administration of histamine and subsequently returned to
the control values with albuterol administration.
The primary FP variable, Δflow, which is a combined variable of
airflow and thoracic volume changes,18 also was higher at Cmax, which
confirmed the findings of the pilot study.11 One aim of our study was
to evaluate which EIT variables best explain Δflow.18,22 Multivariable
analysis suggested that 51% of the variance in Δflow was explained
by a combination of PIFEIT and PEFEIT. This finding was anticipated
because Δflow is calculated in part using airway flow measured by the
pneumotachograph of the FP unit.22 The FVslope also made a small
contribution to the variance in Δflow.
As expected tidal volume did not change significantly with a
change in flow variables with either measuring device during the
study period. Previous studies have identified unchanging tidal vol-
umes during bronchoconstriction in horses.11,25,26 The respiratory
rate increased with histamine and then decreased with albuterol,
whereas tidal volume did not change significantly, indicating an
increase and then subsequent decrease in minute ventilation. The
observed increase in respiratory rate results in a decrease in inspira-
tory24,25 and expiratory time,24 which leads to the measured increase in
flow variables at stable tidal volume. It has been postulated that the
increase in minute ventilation could occur in response to mild hypox-
emia as a consequence of airway narrowing.28
It remains challenging to assess pulmonary mechanics using exis-
ting pulmonary function testing modalities immediately after exer-
cise in the horse. The minimal portable EIT instrumentation which
can be powered by a battery, is noninvasive and does not require a
face mask is well suited to clinical situations. It is possible that EIT
instrumentation can be undertaken in the field, allowing airway sta-
tus to be investigated before and immediately after exercise in
horses suffering from naturally-occurring asthma.37 Given that the
EIT can detect both narrowing and subsequent widening of airways,
it is plausible that EIT will be able to determine the presence of
exercise-induced bronchoconstriction associated with mild asthma
immediately after exercise and test the effects of treatment. Fur-
thermore, the continued development of novel EIT variables may
allow for subtle changes in airway function that are performance lim-
iting but not clinically applicable at rest to be more accurately
assessed.
A detomidine continuous rate infusion was used in our study
because sedation was required for collection of the data that
demanded a tight fitting facemask over an extend time period. The
continuous rate infusion was started immediately after the loading
bolus of detomidine and before instrumentation. The infusion rate
was not changed throughout the study period. This guaranteed a
steady state of sedation and pharmacological parameters for the
duration of the histamine nebulization and subsequent albuterol
administration.38 It also ruled out the possible bronchodilatatory
effects of detomidine.39
A limitation of our study was occasional interference between
the FP instrumentation and the EIT instrumentation because both
emit an electrical signal. This interference was unpredictable and gen-
erally could be filtered out in the postprocessing phase. The variable
most affected by interference was the FVslope. Furthermore, move-
ment artifacts can make EIT evaluation difficult, and different length
of belts might be required to guarantee good electrode-skin contact in
various sizes of horses. The horses in our study were sedated and
movement artifacts therefore were neglectable. We used a custom-
made neoprene electrode belt that fitted all of the horses and allowed
good skin-electrode contact during all measurements without the
need to clip hair.
Another limitation is that albuterol was administered as puffs into
the mask, which makes precise dosing of the drug impossible. The aim
of albuterol administration was to show a gradual improvement of EIT
values back to baseline, which made early measurement after drug
administration necessary. To meet this aim, this method of application
for the albuterol was chosen because it was essential to leave the
mask in place to be able to start data recording immediately. Finally,
healthy horses were used in our study, further studies to validate EIT
using a naturally-occurring airway obstruction model against other
methods of pulmonary function testing will be required to support the
use of this modality as a diagnostic tool for horses with asthma.
5 | CONCLUSION
The EIT variables, PIFEIT and PEFEIT, and the variables derived from
the FV loops, FVslope and FVintercept/VT EIT, detected changes in air-
flow after histamine bronchoprovocation in horses and subsequent
albuterol administration. Global EIT flow variables showed the same
pattern of change as did flow variables measured by spirometry and
best explained Δflow. This modality could be useful to detect changes
in airflow in horses with asthma and further work is required to deter-
mine if a combination of the variables measured by the EIT may be
useful to detect subtle changes in pulmonary function in horses with
asthma.
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